Global Bipolar Disorder Therapeutics Drugs Market Research Report 2023

Report ID: 1875774 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Bipolar Disorder Therapeutics Drugs Market Overview
    1.1 Product Overview and Scope of Bipolar Disorder Therapeutics Drugs
    1.2 Bipolar Disorder Therapeutics Drugs Segment by Type
        1.2.1 Global Bipolar Disorder Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Olanzapine (Zyprexa)
        1.2.3 Quetiapine (Seroquel)
        1.2.4 Risperidone (Risperdal)
        1.2.5 Ariprazole (Abilify)
        1.2.6 Ziprasidone (Geodon)
        1.2.7 Clozapine (Clozaril)
    1.3 Bipolar Disorder Therapeutics Drugs Segment by Application
        1.3.1 Global Bipolar Disorder Therapeutics Drugs Sales Comparison by Application: (2022-2028)
        1.3.2 lumateperone
        1.3.3 Central Nervous System (CNS) Disorders
    1.4 Global Bipolar Disorder Therapeutics Drugs Market Size Estimates and Forecasts
        1.4.1 Global Bipolar Disorder Therapeutics Drugs Revenue 2017-2028
        1.4.2 Global Bipolar Disorder Therapeutics Drugs Sales 2017-2028
        1.4.3 Bipolar Disorder Therapeutics Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Bipolar Disorder Therapeutics Drugs Market Competition by Manufacturers
    2.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Bipolar Disorder Therapeutics Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Bipolar Disorder Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Bipolar Disorder Therapeutics Drugs Market Competitive Situation and Trends
        2.5.1 Bipolar Disorder Therapeutics Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Bipolar Disorder Therapeutics Drugs Players Market Share by Revenue
        2.5.3 Global Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bipolar Disorder Therapeutics Drugs Retrospective Market Scenario by Region
    3.1 Global Bipolar Disorder Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Bipolar Disorder Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
        3.3.1 North America Bipolar Disorder Therapeutics Drugs Sales by Country
        3.3.2 North America Bipolar Disorder Therapeutics Drugs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
        3.4.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Country
        3.4.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Region
        3.5.2 Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
        3.6.1 Latin America Bipolar Disorder Therapeutics Drugs Sales by Country
        3.6.2 Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Country
        3.7.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Bipolar Disorder Therapeutics Drugs Historic Market Analysis by Type
    4.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2022)
    4.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2017-2022)
    4.3 Global Bipolar Disorder Therapeutics Drugs Price by Type (2017-2022)
5 Global Bipolar Disorder Therapeutics Drugs Historic Market Analysis by Application
    5.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2022)
    5.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2017-2022)
    5.3 Global Bipolar Disorder Therapeutics Drugs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 AstraZeneca
        6.1.1 AstraZeneca Corporation Information
        6.1.2 AstraZeneca Description and Business Overview
        6.1.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 AstraZeneca Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.1.5 AstraZeneca Recent Developments/Updates
    6.2 Allergan
        6.2.1 Allergan Corporation Information
        6.2.2 Allergan Description and Business Overview
        6.2.3 Allergan Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Allergan Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.2.5 Allergan Recent Developments/Updates
    6.3 Bristol-Myers Squibb
        6.3.1 Bristol-Myers Squibb Corporation Information
        6.3.2 Bristol-Myers Squibb Description and Business Overview
        6.3.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.3.5 Bristol-Myers Squibb Recent Developments/Updates
    6.4 GSK
        6.4.1 GSK Corporation Information
        6.4.2 GSK Description and Business Overview
        6.4.3 GSK Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 GSK Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.4.5 GSK Recent Developments/Updates
    6.5 Janssen
        6.5.1 Janssen Corporation Information
        6.5.2 Janssen Description and Business Overview
        6.5.3 Janssen Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Janssen Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.5.5 Janssen Recent Developments/Updates
    6.6 AbbVie
        6.6.1 AbbVie Corporation Information
        6.6.2 AbbVie Description and Business Overview
        6.6.3 AbbVie Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 AbbVie Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.6.5 AbbVie Recent Developments/Updates
    6.7 Youdim
        6.6.1 Youdim Corporation Information
        6.6.2 Youdim Description and Business Overview
        6.6.3 Youdim Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Youdim Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.7.5 Youdim Recent Developments/Updates
    6.8 Delpor
        6.8.1 Delpor Corporation Information
        6.8.2 Delpor Description and Business Overview
        6.8.3 Delpor Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Delpor Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.8.5 Delpor Recent Developments/Updates
    6.9 Lundbeck
        6.9.1 Lundbeck Corporation Information
        6.9.2 Lundbeck Description and Business Overview
        6.9.3 Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Lundbeck Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.9.5 Lundbeck Recent Developments/Updates
    6.10 Intra-Cellular Therapies
        6.10.1 Intra-Cellular Therapies Corporation Information
        6.10.2 Intra-Cellular Therapies Description and Business Overview
        6.10.3 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.10.5 Intra-Cellular Therapies Recent Developments/Updates
    6.11 Novartis Pharmaceuticals Corporation
        6.11.1 Novartis Pharmaceuticals Corporation Corporation Information
        6.11.2 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Description and Business Overview
        6.11.3 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.11.5 Novartis Pharmaceuticals Corporation Recent Developments/Updates
    6.12 Noven Pharmaceuticals
        6.12.1 Noven Pharmaceuticals Corporation Information
        6.12.2 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Description and Business Overview
        6.12.3 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.12.5 Noven Pharmaceuticals Recent Developments/Updates
    6.13 Otsuka
        6.13.1 Otsuka Corporation Information
        6.13.2 Otsuka Bipolar Disorder Therapeutics Drugs Description and Business Overview
        6.13.3 Otsuka Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Otsuka Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.13.5 Otsuka Recent Developments/Updates
    6.14 Pfizer
        6.14.1 Pfizer Corporation Information
        6.14.2 Pfizer Bipolar Disorder Therapeutics Drugs Description and Business Overview
        6.14.3 Pfizer Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Pfizer Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.14.5 Pfizer Recent Developments/Updates
    6.15 Reviva Pharmaceuticals
        6.15.1 Reviva Pharmaceuticals Corporation Information
        6.15.2 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Description and Business Overview
        6.15.3 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product Portfolio
        6.15.5 Reviva Pharmaceuticals Recent Developments/Updates
7 Bipolar Disorder Therapeutics Drugs Manufacturing Cost Analysis
    7.1 Bipolar Disorder Therapeutics Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Bipolar Disorder Therapeutics Drugs
    7.4 Bipolar Disorder Therapeutics Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Bipolar Disorder Therapeutics Drugs Distributors List
    8.3 Bipolar Disorder Therapeutics Drugs Customers
9 Bipolar Disorder Therapeutics Drugs Market Dynamics
    9.1 Bipolar Disorder Therapeutics Drugs Industry Trends
    9.2 Bipolar Disorder Therapeutics Drugs Market Drivers
    9.3 Bipolar Disorder Therapeutics Drugs Market Challenges
    9.4 Bipolar Disorder Therapeutics Drugs Market Restraints
10 Global Market Forecast
    10.1 Bipolar Disorder Therapeutics Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Bipolar Disorder Therapeutics Drugs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Bipolar Disorder Therapeutics Drugs by Type (2023-2028)
    10.2 Bipolar Disorder Therapeutics Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Bipolar Disorder Therapeutics Drugs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Bipolar Disorder Therapeutics Drugs by Application (2023-2028)
    10.3 Bipolar Disorder Therapeutics Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Bipolar Disorder Therapeutics Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Bipolar Disorder Therapeutics Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Bipolar Disorder Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Bipolar Disorder Therapeutics Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Bipolar Disorder Therapeutics Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Bipolar Disorder Therapeutics Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Bipolar Disorder Therapeutics Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Bipolar Disorder Therapeutics Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Bipolar Disorder Therapeutics Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Bipolar Disorder Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder Therapeutics Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Bipolar Disorder Therapeutics Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Bipolar Disorder Therapeutics Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Bipolar Disorder Therapeutics Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. AstraZeneca Corporation Information
    Table 50. AstraZeneca Description and Business Overview
    Table 51. AstraZeneca Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. AstraZeneca Bipolar Disorder Therapeutics Drugs Product
    Table 53. AstraZeneca Recent Developments/Updates
    Table 54. Allergan Corporation Information
    Table 55. Allergan Description and Business Overview
    Table 56. Allergan Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Allergan Bipolar Disorder Therapeutics Drugs Product
    Table 58. Allergan Recent Developments/Updates
    Table 59. Bristol-Myers Squibb Corporation Information
    Table 60. Bristol-Myers Squibb Description and Business Overview
    Table 61. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product
    Table 63. Bristol-Myers Squibb Recent Developments/Updates
    Table 64. GSK Corporation Information
    Table 65. GSK Description and Business Overview
    Table 66. GSK Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. GSK Bipolar Disorder Therapeutics Drugs Product
    Table 68. GSK Recent Developments/Updates
    Table 69. Janssen Corporation Information
    Table 70. Janssen Description and Business Overview
    Table 71. Janssen Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Janssen Bipolar Disorder Therapeutics Drugs Product
    Table 73. Janssen Recent Developments/Updates
    Table 74. AbbVie Corporation Information
    Table 75. AbbVie Description and Business Overview
    Table 76. AbbVie Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. AbbVie Bipolar Disorder Therapeutics Drugs Product
    Table 78. AbbVie Recent Developments/Updates
    Table 79. Youdim Corporation Information
    Table 80. Youdim Description and Business Overview
    Table 81. Youdim Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Youdim Bipolar Disorder Therapeutics Drugs Product
    Table 83. Youdim Recent Developments/Updates
    Table 84. Delpor Corporation Information
    Table 85. Delpor Description and Business Overview
    Table 86. Delpor Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Delpor Bipolar Disorder Therapeutics Drugs Product
    Table 88. Delpor Recent Developments/Updates
    Table 89. Lundbeck Corporation Information
    Table 90. Lundbeck Description and Business Overview
    Table 91. Lundbeck Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. Lundbeck Bipolar Disorder Therapeutics Drugs Product
    Table 93. Lundbeck Recent Developments/Updates
    Table 94. Intra-Cellular Therapies Corporation Information
    Table 95. Intra-Cellular Therapies Description and Business Overview
    Table 96. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product
    Table 98. Intra-Cellular Therapies Recent Developments/Updates
    Table 99. Novartis Pharmaceuticals Corporation Corporation Information
    Table 100. Novartis Pharmaceuticals Corporation Description and Business Overview
    Table 101. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product
    Table 103. Novartis Pharmaceuticals Corporation Recent Developments/Updates
    Table 104. Noven Pharmaceuticals Corporation Information
    Table 105. Noven Pharmaceuticals Description and Business Overview
    Table 106. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 107. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product
    Table 108. Noven Pharmaceuticals Recent Developments/Updates
    Table 109. Otsuka Corporation Information
    Table 110. Otsuka Description and Business Overview
    Table 111. Otsuka Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Otsuka Bipolar Disorder Therapeutics Drugs Product
    Table 113. Otsuka Recent Developments/Updates
    Table 114. Pfizer Corporation Information
    Table 115. Pfizer Description and Business Overview
    Table 116. Pfizer Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Pfizer Bipolar Disorder Therapeutics Drugs Product
    Table 118. Pfizer Recent Developments/Updates
    Table 119. Reviva Pharmaceuticals Corporation Information
    Table 120. Reviva Pharmaceuticals Description and Business Overview
    Table 121. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product
    Table 123. Reviva Pharmaceuticals Recent Developments/Updates
    Table 124. Production Base and Market Concentration Rate of Raw Material
    Table 125. Key Suppliers of Raw Materials
    Table 126. Bipolar Disorder Therapeutics Drugs Distributors List
    Table 127. Bipolar Disorder Therapeutics Drugs Customers List
    Table 128. Bipolar Disorder Therapeutics Drugs Market Trends
    Table 129. Bipolar Disorder Therapeutics Drugs Market Drivers
    Table 130. Bipolar Disorder Therapeutics Drugs Market Challenges
    Table 131. Bipolar Disorder Therapeutics Drugs Market Restraints
    Table 132. Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 133. Global Bipolar Disorder Therapeutics Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 134. Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 135. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 136. Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 137. Global Bipolar Disorder Therapeutics Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 138. Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 139. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 140. Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 141. Global Bipolar Disorder Therapeutics Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 142. Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 143. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Bipolar Disorder Therapeutics Drugs
    Figure 2. Global Bipolar Disorder Therapeutics Drugs Market Share by Type in 2021 & 2028
    Figure 3. Olanzapine (Zyprexa) Product Picture
    Figure 4. Quetiapine (Seroquel) Product Picture
    Figure 5. Risperidone (Risperdal) Product Picture
    Figure 6. Ariprazole (Abilify) Product Picture
    Figure 7. Ziprasidone (Geodon) Product Picture
    Figure 8. Clozapine (Clozaril) Product Picture
    Figure 9. Global Bipolar Disorder Therapeutics Drugs Market Share by Application in 2021 & 2028
    Figure 10. lumateperone
    Figure 11. Central Nervous System (CNS) Disorders
    Figure 12. Global Bipolar Disorder Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Bipolar Disorder Therapeutics Drugs Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Bipolar Disorder Therapeutics Drugs Sales (2017-2028) & (K Units)
    Figure 15. Bipolar Disorder Therapeutics Drugs Sales Share by Manufacturers in 2021
    Figure 16. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Bipolar Disorder Therapeutics Drugs Players: Market Share by Revenue in 2021
    Figure 18. Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2017-2022)
    Figure 20. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region in 2021
    Figure 21. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2017-2022)
    Figure 22. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region in 2021
    Figure 23. U.S. Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Taiwan Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Philippines Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Vietnam Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Mexico Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Brazil Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Argentina Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Turkey Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Saudi Arabia Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. U.A.E Bipolar Disorder Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Sales Market Share of Bipolar Disorder Therapeutics Drugs by Type (2017-2022)
    Figure 48. Manufacturing Cost Structure of Bipolar Disorder Therapeutics Drugs
    Figure 49. Manufacturing Process Analysis of Bipolar Disorder Therapeutics Drugs
    Figure 50. Bipolar Disorder Therapeutics Drugs Industrial Chain Analysis
    Figure 51. Channels of Distribution
    Figure 52. Distributors Profiles
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Allergan
Bristol-Myers Squibb
GSK
Janssen
AbbVie
Youdim
Delpor
Lundbeck
Intra-Cellular Therapies
Novartis Pharmaceuticals Corporation
Noven Pharmaceuticals
Otsuka
Pfizer
Reviva Pharmaceuticals
Frequently Asked Questions
Bipolar Disorder Therapeutics Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Bipolar Disorder Therapeutics Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Bipolar Disorder Therapeutics Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bistoury

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More